COACH-Cog for Dementia Patients Facing Cancer Decisions (COACH-Cog Trial)

N/A

Recruiting

Led By Allison Magnuson

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a new intervention called COACH-Cog for older adults with Alzheimer's disease and related dementias who are also dealing with cancer. The researchers believe that COACH-Cog

Who is the study for?

This trial is for older adults with Alzheimer's Disease or related dementias (ADRD) who also have to make decisions about cancer treatment. They need a care partner involved in the decision-making process. Specific eligibility details are not provided, but typically participants must meet certain health and cognitive criteria.

What is being tested?

The study tests COACH-Cog, a communication aid designed to help patients with ADRD and their care partners make informed decisions about cancer treatments. The goal is to support autonomy and ensure that treatment choices align with the patient's values and preferences.

What are the potential side effects?

Since COACH-Cog is a communication intervention rather than a medical treatment, it does not have physical side effects like drugs do. However, its impact on emotional well-being and decision-making processes will be closely monitored.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Care Partner: Health Care Climate Questionnaire (HCCQ)

Secondary study objectives

Care Partner PROMIS Depression

Care partner PROMIS Anxiety

Care partner: Decision Regret Scale

+5 more

Other study objectives

Patient Decision Regret Scale

Patient: Health Care Climate Questionnaire (HCCQ)

Patient: Health Care Climate Questionnaire - Age (HCCQ-Age)

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: COACH-Cog InterventionExperimental Treatment1 Intervention

Oncology clinician intervention components: 1) a brief training video, 2) For each patient/care partner dyad that is subsequently enrolled onto the study that the clinician cares for, the oncology clinician will receive the results of the patient's GA with targeted management recommendations for identified GA domain impairments. Patient/Care partner dyad intervention components: 1) Communication coaching session; 2) Patient GA results with management recommendations to consider discussing with the oncology team will be provided to care partners and patients.

Group II: Usual CareActive Control1 Intervention

Usual Care

Do I qualify?Apply below to find out